(Q47235844)

http://europepmc.org/abstract/MED/29063585

12 January 2018

meta-analysis

0 references

title

Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485683&resulttype=core&format=json

14 May 2020

1 reference

bronchopulmonary dysplasia

1 reference

inferred from title

author

Richard A. Ehrenkranz

3

object named as

Richard A Ehrenkranz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485683&resulttype=core&format=json

14 May 2020

author name string

Lex W Doyle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485683&resulttype=core&format=json

14 May 2020

Jeanie L Cheong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485683&resulttype=core&format=json

14 May 2020

Henry L Halliday

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485683&resulttype=core&format=json

14 May 2020

publication date

24 October 2017

1 reference

http://europepmc.org/abstract/MED/29063585

12 January 2018

published in

Cochrane Database of Systematic Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485683&resulttype=core&format=json

14 May 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485683&resulttype=core&format=json

14 May 2020

page(s)

CD001146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485683&resulttype=core&format=json

Early neonatal dexamethasone treatment for prevention of bronchopulmonary dysplasia. Randomised trial and meta-analysis evaluating the duration of dexamethasone therapy.

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Feasibility study of early blood pressure management in extremely preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks gestation: results of the THORN trial--thyroid hormone replacement in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Adding hydrocortisone as 1st line of inotropic treatment for hypotension in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Trial of early neonatal hydrocortisone: two-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Randomised trial of early neonatal hydrocortisone demonstrates potential undesired effects on neurodevelopment at preschool age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Early postnatal dexamethasone treatment and increased incidence of cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Maternal nutrition and birth weight. These factors are related

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

The effects of early postnatal dexamethasone therapy on pulmonary outcome in premature infants with respiratory distress syndrome: a two-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Early dexamethasone therapy in preterm infants: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Pulse dexamethasone does not impair growth and body composition of very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: II. Respiratory status, growth, and blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Dexamethasone therapy increases infection in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

A three year follow up of preterm infants after moderately early treatment with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

[Hydrocortisone for the treatment of refractory hypotension: a randomized controlled trial].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Experience with oral betamethasone in extremely low birthweight infants with bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Early (4-7 days of age) dexamethasone therapy for prevention of chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Early dexamethasone treatment in preterm infants treated with surfactant: a double blind controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Growth retardation after dexamethasone administration: assessment by knemometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

The influence of betamethasone and dexamethasone on motor development in young rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Inflammatory mediators and bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Clinical trials of postnatal corticosteroids: inhaled and systemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Caffeine Therapy for Apnea of Prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

The therapeutic use of glucocorticoid hormones in the perinatal period: Potential neurological hazards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB5

Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy

21 January 2018

1 reference

12 December 2020

Single-dose dexamethasone treatment of hypotension in preterm infants

1 reference

12 December 2020

Randomized placebo-controlled trial of a 42-Day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants.

1 reference

12 December 2020

A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial

1 reference

12 December 2020

Early dexamethasone therapy and blood cell count in preterm infants

1 reference

12 December 2020

Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants

1 reference

12 December 2020

Vascular endothelial growth factor in pulmonary lavage fluid from premature infants: effects of age and postnatal dexamethasone

1 reference

12 December 2020

Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial

1 reference

12 December 2020

Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants

1 reference

12 December 2020

Early dexamethasone-attempting to prevent chronic lung disease

1 reference

12 December 2020

More trials on early treatment with corticosteroids are needed

1 reference

12 December 2020

Early postnatal dexamethasone therapy for the prevention of chronic lung disease

1 reference

12 December 2020

Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth.

1 reference

12 December 2020

Dexamethasone for neonatal chronic lung disease

1 reference

12 December 2020

Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age

1 reference

12 December 2020

Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia

1 reference

12 December 2020

Early low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial

1 reference

12 December 2020

Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Collaborative Dexamethasone Trial Group

1 reference

12 December 2020

Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial

1 reference

12 December 2020

Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation

1 reference

12 December 2020

Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial

1 reference

12 December 2020

Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia

1 reference

12 December 2020

A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome

1 reference

12 December 2020

Sequelae of early steroid administration to the newborn infant

1 reference

12 December 2020

Using cerebral palsy data in the evaluation of neonatal intensive care: a warning

1 reference

12 December 2020

Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up.

1 reference

12 December 2020

Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.

1 reference

12 December 2020

Dexamethasone treatment of infants at risk for chronic lung disease: surfactant components and inflammatory parameters in airway specimens

1 reference

12 December 2020

Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome

1 reference

12 December 2020

Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia

1 reference

12 December 2020

Influence of postnatally administered glucocorticoids on rat lung growth

1 reference

12 December 2020

Cardiac effects of dexamethasone in very low birth weight infants.

1 reference

12 December 2020

A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants

1 reference

12 December 2020

Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant-substituted preterm infants

1 reference

12 December 2020

Prediction of chronic neonatal lung disease on day 4 of life.

1 reference

12 December 2020

Effect of five days of dexamethasone therapy on ventilator dependence and adrenocorticotropic hormone-stimulated cortisol concentrations

1 reference

12 December 2020

Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation

1 reference

12 December 2020

Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial

1 reference

12 December 2020

The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome

1 reference

12 December 2020

A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants

1 reference

12 December 2020

Effect of dexamethasone therapy on the neonatal ductus arteriosus

1 reference

12 December 2020

Role of early postnatal dexamethasone in respiratory distress syndrome

1 reference

12 December 2020

Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity

1 reference

12 December 2020

Effects of early postnatal dexamethasone therapy on calcium homeostasis and bone growth in preterm infants with respiratory distress syndrome

1 reference

12 December 2020

10.1002/14651858.CD001146.PUB5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485683&resulttype=core&format=json

release_dr7sgz53zfa7zfs2rnwqgzfzgu

14 May 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dr7sgz53zfa7zfs2rnwqgzfzgu

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485683&resulttype=core&format=json

14 May 2020

1 reference